OwlBrief

Stay informed, stay wise!

OwlBrief distills the world’s top news into fast, AI-crafted briefs. Stay informed, save time, and get smarter — before your coffee gets cold.

Create account Log in
#Public Health
STAT
STAT
1mth ago 40 views

Winner of mRNA Nobel Prize says ACIP member’s claim that Covid vaccines persist is “absolutely impossible”

Drew Weissman, Nobel Prize winner, dismisses claims about Covid vaccine safety, asserting extensive research supports their efficacy and safety.
Winner of mRNA Nobel Prize says ACIP member’s claim that Covid vaccines persist is “absolutely impossible”
A What happened
Drew Weissman, a professor at the University of Pennsylvania and co-recipient of the 2023 Nobel Prize in Physiology and Medicine, addressed concerns raised by ACIP member Retsef Levi regarding the safety of mRNA Covid vaccines. At a recent CDC meeting, Levi suggested that mRNA, lipid nanoparticles, and spike proteins from the vaccines may persist in the body and provoke unknown immune responses. Weissman countered these claims, stating that extensive literature supports the safety and rapid degradation of mRNA. He highlighted that while some studies may suggest prolonged presence, they often rely on flawed methodologies. Weissman affirmed that mRNA does not circulate widely in the body and that vaccines have been tested extensively, proving to be safer than other vaccine platforms. He expressed concern over the ACIP's recent decisions to limit vaccine availability, emphasizing the historical impact of vaccines in saving lives.

Key insights

  • 1

    Vaccine Safety

    Weissman asserts extensive research confirms mRNA vaccines are safe.

  • 2

    Rapid mRNA Degradation

    Claims of mRNA persistence in the body are refuted by scientific evidence.

  • 3

    Impact of Vaccines

    Vaccines have historically saved millions of lives, according to Weissman.

Takeaways

Weissman's statements reinforce the scientific consensus on the safety and efficacy of mRNA Covid vaccines.

Read the full article on STAT